{ "resourceType": "Questionnaire", "id": "questionnaire-ID001", "meta": { "versionId": "1", "lastUpdated": "2025-11-11T22:30:00Z", "profile": [ "http://hl7.org/fhir/uv/rtq/StructureDefinition/rtq-questionnaire" ] }, "identifier": [ { "system": "http://hl7.org/fhir/uv/brr/identifier/qa-request", "value": "ID001", "type": { "coding": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/rtq-identifier-type", "code": "regulator-id", "display": "Regulator-issued Identifier" } ] } }, { "system": "https://ema.europa.eu/procedure-number", "value": "EMEA/H/C/005432/II/0023", "type": { "coding": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/rtq-identifier-type", "code": "regulator-id", "display": "Regulator-issued Identifier" } ] } } ], "version": "1.1.5", "name": "BRRRegulatoryQAQuestionnaire", "title": "Question Set ID001", "status": "active", "subjectType": [ "MedicinalProductDefinition" ], "date": "2025-11-11", "contact": [ { "purpose": { "coding": [ { "system": "http://hl7.org/fhir/uv/brr/CodeSystem/contact-purpose", "code": "SENDER", "display": "Sender (Health Authority)" } ] }, "organization": { "reference": "Organization/ema", "identifier": { "system": "https://ema.europa.eu/organization-id", "value": "EMA-ORG-001" }, "display": "European Medicines Agency", "name": "European Medicines Agency", "address": { "line": [ "Domenico Scarlattilaan 6" ], "city": "Amsterdam", "postalCode": "1083 HS", "country": "NL" }, "contact": [ { "telecom": [ { "system": "email", "value": "jane.doe@ema.europa.eu" }, { "system": "phone", "value": "+31-88-781-6000" } ] } ] } }, { "purpose": { "coding": [ { "system": "http://hl7.org/fhir/uv/brr/CodeSystem/contact-purpose", "code": "RECIPIENT", "display": "Recipient (Marketing Authorization Holder)" } ] }, "organization": { "reference": "Organization/synthpharma", "identifier": { "system": "urn:oid:1.3.6.1.4.1.519.1", "value": "DUNS-123456789" }, "display": "SynthPharma AG", "name": "SynthPharma AG", "address": { "line": [ "123 Synthetic Research Blvd" ], "city": "Basel", "postalCode": "4000", "country": "CH" }, "contact": [ { "telecom": [ { "system": "email", "value": "john.doe@synthpharma.example" }, { "system": "phone", "value": "+41-61-123-4567" } ] } ] } } ], "item": [ { "linkId": "admin-1", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.0", "display": "1.0 Administrative Information" }, { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.1", "display": "1.1 Application Form" } ], "type": "question", "text": "Is the fee for the Type II variation fully paid and documented?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "
Is the fee for the Type II variation fully paid and documented?
See EMA Fee Guidance for payment confirmation requirements.
Are all required metadata fields in the application form complete?
Do the updated storage conditions (2–8°C for 36 months) require additional patient guidance?
Current ePI states: “Store in a refrigerator (2°C – 8°C). Do not freeze.”
Is the patient leaflet revised to clarify the extended shelf life?
“Shelf life after first opening: 36 months when stored at 2–8°C”
Is the updated ePI text sufficiently clear for all EU languages?
| Language | Status |
|---|---|
| English | Approved |
| French | Under Review |
| German | Pending |
Are there any new stability studies conducted, or does the submission include only data from additional timepoints from previously submitted studies?
Does the data support all intended climatic zones?
Are the test methods used the same as in the previously submitted stability information?
If changed: justify and provide validation data.
Are there any new degradation products identified within the newly submitted data?
Threshold: >0.10% per ICH Q3B(R2)
Any changes in the packaging configuration and/or storage of the samples during stability?
Figure 1: Cross-section of new Alu/Alu blister showing foil thickness and sealing layer.
| Original | New |
|---|---|
| PVC/PVDC Blister | Alu/Alu Blister |
| 25°C/60% RH | Unchanged |